Facebook Twitter LinkedIn Google Plus RSS

Biopharma startup locates in CCIT

By ,

Sunnylife Pharma, a startup biopharmaceutical company launched by a team of former Merck scientists, has taken space in the Commercialization Center for Innovative Technologies, the New Brunswick-based life sciences incubator run by the state’s Economic Development Authority.

The company is focused on developing drugs to fulfill unmet needs of cancer patients and people suffering from cardiovascular and metabolic diseases, with the goal of reducing research and development costs associated with pre-clinical research.

Sunnylife joins other startup tenants such as Aucta PharmaceuticalsQuixgen, and Grace Therapeutics.

“I discovered CCIT based on recommendations from several former colleagues and found the staff to be very welcoming and the facilities well-suited to our needs,” said Sunnylife’s co-founder and CEO, Xibin Liao.

Also Popular on NJBIZ

Vince Calio

Vince Calio

Vince Calio covers health care and manufacturing for NJBIZ. You can contact him at vcalio@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy